{
    "clinical_study": {
        "@rank": "16718", 
        "arm_group": {
            "arm_group_label": "Patients with Chronic Lymphatic Leukemia", 
            "description": "Patients with Chronic Lymphatic Leukemia treated with splenic irradiation"
        }, 
        "brief_summary": {
            "textblock": "Retrospective evaluation on the effect of splenic irradiation on clinical and hematological\n      response and toxicity in patients with chronic lymphatic leukaemia (CLL)."
        }, 
        "brief_title": "Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Leukemia, Chronic Lymphatic", 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Lymphocytic, Chronic, B-Cell", 
                "Leukemia, Lymphoid", 
                "Chronic Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study will include patients with CLL treated with splenic irradiation in Maastro Clinic,\n      Maastricht, The Netherlands, Maxima Medisch Centrum Veldhoven/Catharina hospital, Eindhoven,\n      The Netherlands and Modena hospital, Modena, Italy. Data will be collected from patient\n      records in an uniform database. Data will include demographic data, CLL stadium (RAI and\n      Binet) at diagnosis and at the time of irradiation treatment, clinical data at diagnosis\n      (haematology), splenic irradiation data, follow-up data such as date of progression or death"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with chronic lymphatic leukaemia.\n\n        Exclusion Criteria:\n\n          -  none"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with chronic lymphatic leukaemia (CLL)."
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02020109", 
            "org_study_id": "13-11-05/06-extern-6295"
        }, 
        "intervention": {
            "arm_group_label": "Patients with Chronic Lymphatic Leukemia", 
            "intervention_name": "splenic irradiation", 
            "intervention_type": "Radiation"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 23, 2013", 
        "location": {
            "contact": {
                "last_name": "Jacques Borger, Dr."
            }, 
            "facility": {
                "address": {
                    "city": "Maastricht", 
                    "country": "Netherlands"
                }, 
                "name": "Maastro Clinic"
            }, 
            "investigator": [
                {
                    "last_name": "Jacques Borger, Dr.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Roel Schlijper", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_groups": "1", 
        "official_title": "Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia (CLL)", 
        "overall_contact": {
            "email": "jacques.borger@maastro.nl", 
            "last_name": "Jacques Borger, Dr."
        }, 
        "overall_official": {
            "affiliation": "Maastro Clinic, The Netherlands", 
            "last_name": "Jacques Borger, dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Netherlands:  Independent Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Clinical and haematological response measured by number of leucocytes and thrombocytes during and after irradiation. Hemoglobin and size of spleen during and after irradiation in the time period 2000 tot 2013", 
            "measure": "Clinical and haematological response", 
            "safety_issue": "No", 
            "time_frame": "13 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02020109"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Progression of chronic Lymphatic leukaemia after irradiation in the time period 2000 tot 2013", 
                "measure": "Progression of chronic Lymphatic leukaemia", 
                "safety_issue": "No", 
                "time_frame": "13 years"
            }, 
            {
                "description": "Patients will be followed from the time of splenic irradiation to death in the time period of 2000 tot 2013", 
                "measure": "Death", 
                "safety_issue": "No", 
                "time_frame": "13 years"
            }, 
            {
                "description": "Toxicity of splenic irradiation during and after irradiation measured by evaluating clinical toxicity based on the CTCAE version 3.0 during and after irradiation (2000 to 2013)", 
                "measure": "Toxicity of splenic irradiation", 
                "safety_issue": "No", 
                "time_frame": "13 years"
            }
        ], 
        "source": "Maastricht Radiation Oncology", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Maastricht Radiation Oncology", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}